• Biomarker Tool for Pre-Clinical Research into kidney Function

Laboratory Products

Biomarker Tool for Pre-Clinical Research into kidney Function

Feb 12 2010

Invitrogen announced the global availability of a new biomarker tool for use in pre-clinical research into kidney function. The PlexMark™ 3 Renal Biomarker Panel Assay is a non-invasive and cost-effective research tool for performing post-transplantation kidney function studies rapidly and easily. The introduction of this research tool is expected to help in the development of studies, which may lead to more effective methods for monitoring
kidney health in transplant research.

This new assay provides researchers with an alternative to invasive and expensive procedures, such as biopsies, used to obtain kidney tissue samples to allow research into posttransplantation kidney function. The PlexMark 3 Renal Biomarker Panel Assay measures levels of cytokines, chemokines and receptor levels in urine, which give researchers a better understanding of immune function and response. This may lead to the development of new, non-invasive tests to monitor kidney function and health following transplant procedures.

The PlexMark assay uses Luminex® xMAP® multiplexing technology for bioassay analysis, in a standard immunoassay format to offer ease-of-use, sensitivity and rapid, reproducible results. The biomarkers in the PlexMark panel are licensed from Renovar Inc, a pioneer in the development of new tools for assessing kidney inflammation for numerous clinical indications.

Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

View all events